Ladder Capital Corp Q3 2026 Earnings Call Summary – Moby Strategic Performance and Market Positioning Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here. Performance was driven by a $31 million gain from the

Salesforce Stock Is Up About 30% Since July 31. Here’s Where It Could Go by 2031 ©@Blue Planet Studio from Getty Images via Canva, @Blue Planet Studio from Getty Images via Canva Key Stats for Salesforce Stock Current Price: $246.74 Target Price (Mid): ~$445 Street Target: ~$286 Potential Total Return: ~81% Annualized IRR: ~15% /

Micron (NASDAQ: MU) has been a great stock to own in 2026, but I’m betting that it goes even higher by 2030. In fact, it could transform a $10,000 investment made today into a $42,000 position by then — and that’s on the conservative side of my estimated range. That may seem unrealistic, but the

AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years ©89Stocker, towfiqu barbhuiya via Canva Key Takeaways AbbVie lowered its 2026 adjusted EPS guidance to $13.76 to $13.96 on Oct. 5, reflecting $1.25 billion of acquired IPR&D and milestone expense. Altria yields 6.2% against AbbVie’s 2.6%, while AbbVie raised its dividend

Palantir (PLTR) was breaking records earlier this week. Now its breakout has reversed, with the stock heading toward correction territory. Shares fell roughly 7% Friday, erasing about $34 billion in market value. The closing number to watch is $188.15. Below that, Palantir would finish more than 10% beneath its Oct. 9 record close, confirming a

Quick Read AAPL turned $10,000 into $127,753 over the last decade, but its $4.96T market cap limits the next 5-year base case to roughly $16,271. iPhone 17 revenue surged 22% to $54B and Services hit $30.7B, powering a record $109B June quarter for Apple. Valuation at 39x earnings, shrinking gross margins, and iPhone 18 Pro

CoreWeave (CRWV) sprang a bear trap Thursday. Now another sell-off is testing whether the bulls can hold their ground. The AI cloud provider’s shares are falling Friday after staging a dramatic reversal the previous session. Shares briefly broke below their summer floor near $60 on Thursday, sank to $59.51, then climbed to $69.76 — a

What happened: Moderna (MRNA) stock tanked 9% on Friday. What’s behind the move: The biotech giant sank as investors took profits and Wall Street grew cautious on the stock’s blistering rally of more than 600% year to date. Goldman Sachs (GS) raised its target on the stock to $137 from $120 on Thursday while maintaining a Neutral

It’s no secret that stocks connected to the AI industry have been some of the market’s top performers over the past year, but there are still a few that remain relatively under the radar. Silicon Motion Technology (NASDAQ: SIMO) is one of them. It produces NAND flash controllers, which are vital for AI infrastructure. That’s

Harris Oakmark recently released its third-quarter 2026 investor letter for its “Oakmark Global Select Fund”. It is a non-diversified fund that focuses on long-term capital appreciation by investing in common stocks of U.S. and non-U.S. companies. The letter can be downloaded here. The Fund (Investor Class) returned 5.14% for the quarter, surpassing the MSCI World

In recent years, artificial intelligence (AI) stocks soared in the triple and quadruple digits, leading the S&P 500 higher. Investors rushed to get in on the next big tech growth story, a technology with the potential to transform how many things are done and, as a result, fuel significant gains in corporate earnings. Companies such

Japanese financials suddenly sit in the spotlight as the Bank of Japan hints at tighter policy and questions mount over how far inflation might run. Lending, insurance and balance sheets all feel different when rates move, and that can shift the story for specific stocks in a hurry. This article explains how that backdrop relates